Faheem Hasnain is a prominent entrepreneur and executive with extensive experience in the biotechnology and life sciences sectors. Currently serving as Founder, CEO, and Chairman at Gossamer Bio since January 2018, Hasnain also holds various leadership positions, including Chairman of the Board at Sling Therapeutics and Aspen Neuroscience, and Chairman at SENTÉ®. Additionally, Hasnain acts as the Independent Lead Director at Kura Oncology, and provides strategic advice to Vertex Ventures and TPG. Previously, Hasnain was Chairman at Mirati Therapeutics until January 2024, Chairman of Tocagen Inc. until January 2020, and Chairman of Vital Therapies, Inc. until March 2019. Hasnain earned a Bachelor of Human Kinetics and a Bachelor of Education from the University of Windsor from 1978 to 1983.
This person is not in the org chart
This person is not in any teams
This person is not in any offices